Global Atorvastatin Calcium Market Research Report 2023

Publisher Name :
Date: 03-Jan-2023
No. of pages: 102
Inquire Before Buying

Atorvastatin calcium is a pharmaceutical raw material in the production of atorvastatin calcium drug (trade name: Lipitor), which is a prescription medicine that lowers the LDL cholesterol and triglycerides in the blood and can raise HDL cholesterol as well. Atorvastatin calcium usually is white powder and whose CAS number is 134523-03-8.

Highlights

The global Atorvastatin Calcium market was valued at US$ 219 million in 2022 and is anticipated to reach US$ 365.5 million by 2029, witnessing a CAGR of 7.5% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

The key players of global Atorvastatin Calcium include Pfizer, DSM Sinochem Pharmaceuticals, Ind-Swift, Cadila Pharmaceuticals, Morepen and Sun Pharmaceutical Industries. Pfizer is the leader of this industry with about 26% market shares. India and China are the main consumption bases, and India holds 35% consumption share, and China holds 18% consumption share. They occupy 54% of the global consumption in total.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Atorvastatin Calcium, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Atorvastatin Calcium.

The Atorvastatin Calcium market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Atorvastatin Calcium market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Atorvastatin Calcium manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

By Company

- Pfizer

- DSM Sinochem Pharmaceuticals

- Ind-Swift

- Cadila Pharmaceuticals

- Morepen

- Sun Pharmaceutical Industries

- MSN Laboratories

- Dr. Reddy's

- Teva Pharmaceutical Industries

- Apotex Pharmachem

- Zheijang Neo-Dankon Pharmaceutical

- Ningbo Menovo Pharmaceuticals Group

- Jialin Pharmaceutical

- Topfond

- Zhejiang Hisun Pharmacutical

- Zhejiang Hongyuan Pharmaceutical

- Hubei Yitai Pharmaceutical

- Jiangsu Hengrui Medicine

Segment by Type

- Chemical Synthesis

- Biocatalysis

Segment by Application

- Tablet (Including Dispersible Tablet and General Tablet)

- Capsule

- Others

Consumption by Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Atorvastatin Calcium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Atorvastatin Calcium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

Global Atorvastatin Calcium Market Research Report 2023

Table of Contents
1 Atorvastatin Calcium Market Overview
1.1 Product Overview and Scope of Atorvastatin Calcium
1.2 Atorvastatin Calcium Segment by Type
1.2.1 Global Atorvastatin Calcium Market Value Comparison by Type (2023-2029)
1.2.2 Chemical Synthesis
1.2.3 Biocatalysis
1.3 Atorvastatin Calcium Segment by Application
1.3.1 Global Atorvastatin Calcium Market Value by Application: (2023-2029)
1.3.2 Tablet (Including Dispersible Tablet and General Tablet)
1.3.3 Capsule
1.3.4 Others
1.4 Global Atorvastatin Calcium Market Size Estimates and Forecasts
1.4.1 Global Atorvastatin Calcium Revenue 2018-2029
1.4.2 Global Atorvastatin Calcium Sales 2018-2029
1.4.3 Global Atorvastatin Calcium Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Atorvastatin Calcium Market Competition by Manufacturers
2.1 Global Atorvastatin Calcium Sales Market Share by Manufacturers (2018-2023)
2.2 Global Atorvastatin Calcium Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Atorvastatin Calcium Average Price by Manufacturers (2018-2023)
2.4 Global Atorvastatin Calcium Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Atorvastatin Calcium, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Atorvastatin Calcium, Product Type & Application
2.7 Atorvastatin Calcium Market Competitive Situation and Trends
2.7.1 Atorvastatin Calcium Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Atorvastatin Calcium Players Market Share by Revenue
2.7.3 Global Atorvastatin Calcium Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Atorvastatin Calcium Retrospective Market Scenario by Region
3.1 Global Atorvastatin Calcium Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Atorvastatin Calcium Global Atorvastatin Calcium Sales by Region: 2018-2029
3.2.1 Global Atorvastatin Calcium Sales by Region: 2018-2023
3.2.2 Global Atorvastatin Calcium Sales by Region: 2024-2029
3.3 Global Atorvastatin Calcium Global Atorvastatin Calcium Revenue by Region: 2018-2029
3.3.1 Global Atorvastatin Calcium Revenue by Region: 2018-2023
3.3.2 Global Atorvastatin Calcium Revenue by Region: 2024-2029
3.4 North America Atorvastatin Calcium Market Facts & Figures by Country
3.4.1 North America Atorvastatin Calcium Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Atorvastatin Calcium Sales by Country (2018-2029)
3.4.3 North America Atorvastatin Calcium Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Atorvastatin Calcium Market Facts & Figures by Country
3.5.1 Europe Atorvastatin Calcium Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Atorvastatin Calcium Sales by Country (2018-2029)
3.5.3 Europe Atorvastatin Calcium Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Atorvastatin Calcium Market Facts & Figures by Country
3.6.1 Asia Pacific Atorvastatin Calcium Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Atorvastatin Calcium Sales by Country (2018-2029)
3.6.3 Asia Pacific Atorvastatin Calcium Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Atorvastatin Calcium Market Facts & Figures by Country
3.7.1 Latin America Atorvastatin Calcium Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Atorvastatin Calcium Sales by Country (2018-2029)
3.7.3 Latin America Atorvastatin Calcium Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Atorvastatin Calcium Market Facts & Figures by Country
3.8.1 Middle East and Africa Atorvastatin Calcium Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Atorvastatin Calcium Sales by Country (2018-2029)
3.8.3 Middle East and Africa Atorvastatin Calcium Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Atorvastatin Calcium Sales by Type (2018-2029)
4.1.1 Global Atorvastatin Calcium Sales by Type (2018-2023)
4.1.2 Global Atorvastatin Calcium Sales by Type (2024-2029)
4.1.3 Global Atorvastatin Calcium Sales Market Share by Type (2018-2029)
4.2 Global Atorvastatin Calcium Revenue by Type (2018-2029)
4.2.1 Global Atorvastatin Calcium Revenue by Type (2018-2023)
4.2.2 Global Atorvastatin Calcium Revenue by Type (2024-2029)
4.2.3 Global Atorvastatin Calcium Revenue Market Share by Type (2018-2029)
4.3 Global Atorvastatin Calcium Price by Type (2018-2029)
5 Segment by Application
5.1 Global Atorvastatin Calcium Sales by Application (2018-2029)
5.1.1 Global Atorvastatin Calcium Sales by Application (2018-2023)
5.1.2 Global Atorvastatin Calcium Sales by Application (2024-2029)
5.1.3 Global Atorvastatin Calcium Sales Market Share by Application (2018-2029)
5.2 Global Atorvastatin Calcium Revenue by Application (2018-2029)
5.2.1 Global Atorvastatin Calcium Revenue by Application (2018-2023)
5.2.2 Global Atorvastatin Calcium Revenue by Application (2024-2029)
5.2.3 Global Atorvastatin Calcium Revenue Market Share by Application (2018-2029)
5.3 Global Atorvastatin Calcium Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Atorvastatin Calcium Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Pfizer Atorvastatin Calcium Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 DSM Sinochem Pharmaceuticals
6.2.1 DSM Sinochem Pharmaceuticals Corporation Information
6.2.2 DSM Sinochem Pharmaceuticals Description and Business Overview
6.2.3 DSM Sinochem Pharmaceuticals Atorvastatin Calcium Sales, Revenue and Gross Margin (2018-2023)
6.2.4 DSM Sinochem Pharmaceuticals Atorvastatin Calcium Product Portfolio
6.2.5 DSM Sinochem Pharmaceuticals Recent Developments/Updates
6.3 Ind-Swift
6.3.1 Ind-Swift Corporation Information
6.3.2 Ind-Swift Description and Business Overview
6.3.3 Ind-Swift Atorvastatin Calcium Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Ind-Swift Atorvastatin Calcium Product Portfolio
6.3.5 Ind-Swift Recent Developments/Updates
6.4 Cadila Pharmaceuticals
6.4.1 Cadila Pharmaceuticals Corporation Information
6.4.2 Cadila Pharmaceuticals Description and Business Overview
6.4.3 Cadila Pharmaceuticals Atorvastatin Calcium Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Cadila Pharmaceuticals Atorvastatin Calcium Product Portfolio
6.4.5 Cadila Pharmaceuticals Recent Developments/Updates
6.5 Morepen
6.5.1 Morepen Corporation Information
6.5.2 Morepen Description and Business Overview
6.5.3 Morepen Atorvastatin Calcium Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Morepen Atorvastatin Calcium Product Portfolio
6.5.5 Morepen Recent Developments/Updates
6.6 Sun Pharmaceutical Industries
6.6.1 Sun Pharmaceutical Industries Corporation Information
6.6.2 Sun Pharmaceutical Industries Description and Business Overview
6.6.3 Sun Pharmaceutical Industries Atorvastatin Calcium Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Sun Pharmaceutical Industries Atorvastatin Calcium Product Portfolio
6.6.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.7 MSN Laboratories
6.6.1 MSN Laboratories Corporation Information
6.6.2 MSN Laboratories Description and Business Overview
6.6.3 MSN Laboratories Atorvastatin Calcium Sales, Revenue and Gross Margin (2018-2023)
6.4.4 MSN Laboratories Atorvastatin Calcium Product Portfolio
6.7.5 MSN Laboratories Recent Developments/Updates
6.8 Dr. Reddy's
6.8.1 Dr. Reddy's Corporation Information
6.8.2 Dr. Reddy's Description and Business Overview
6.8.3 Dr. Reddy's Atorvastatin Calcium Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Dr. Reddy's Atorvastatin Calcium Product Portfolio
6.8.5 Dr. Reddy's Recent Developments/Updates
6.9 Teva Pharmaceutical Industries
6.9.1 Teva Pharmaceutical Industries Corporation Information
6.9.2 Teva Pharmaceutical Industries Description and Business Overview
6.9.3 Teva Pharmaceutical Industries Atorvastatin Calcium Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Teva Pharmaceutical Industries Atorvastatin Calcium Product Portfolio
6.9.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.10 Apotex Pharmachem
6.10.1 Apotex Pharmachem Corporation Information
6.10.2 Apotex Pharmachem Description and Business Overview
6.10.3 Apotex Pharmachem Atorvastatin Calcium Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Apotex Pharmachem Atorvastatin Calcium Product Portfolio
6.10.5 Apotex Pharmachem Recent Developments/Updates
6.11 Zheijang Neo-Dankon Pharmaceutical
6.11.1 Zheijang Neo-Dankon Pharmaceutical Corporation Information
6.11.2 Zheijang Neo-Dankon Pharmaceutical Atorvastatin Calcium Description and Business Overview
6.11.3 Zheijang Neo-Dankon Pharmaceutical Atorvastatin Calcium Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Zheijang Neo-Dankon Pharmaceutical Atorvastatin Calcium Product Portfolio
6.11.5 Zheijang Neo-Dankon Pharmaceutical Recent Developments/Updates
6.12 Ningbo Menovo Pharmaceuticals Group
6.12.1 Ningbo Menovo Pharmaceuticals Group Corporation Information
6.12.2 Ningbo Menovo Pharmaceuticals Group Atorvastatin Calcium Description and Business Overview
6.12.3 Ningbo Menovo Pharmaceuticals Group Atorvastatin Calcium Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Ningbo Menovo Pharmaceuticals Group Atorvastatin Calcium Product Portfolio
6.12.5 Ningbo Menovo Pharmaceuticals Group Recent Developments/Updates
6.13 Jialin Pharmaceutical
6.13.1 Jialin Pharmaceutical Corporation Information
6.13.2 Jialin Pharmaceutical Atorvastatin Calcium Description and Business Overview
6.13.3 Jialin Pharmaceutical Atorvastatin Calcium Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Jialin Pharmaceutical Atorvastatin Calcium Product Portfolio
6.13.5 Jialin Pharmaceutical Recent Developments/Updates
6.14 Topfond
6.14.1 Topfond Corporation Information
6.14.2 Topfond Atorvastatin Calcium Description and Business Overview
6.14.3 Topfond Atorvastatin Calcium Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Topfond Atorvastatin Calcium Product Portfolio
6.14.5 Topfond Recent Developments/Updates
6.15 Zhejiang Hisun Pharmacutical
6.15.1 Zhejiang Hisun Pharmacutical Corporation Information
6.15.2 Zhejiang Hisun Pharmacutical Atorvastatin Calcium Description and Business Overview
6.15.3 Zhejiang Hisun Pharmacutical Atorvastatin Calcium Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Zhejiang Hisun Pharmacutical Atorvastatin Calcium Product Portfolio
6.15.5 Zhejiang Hisun Pharmacutical Recent Developments/Updates
6.16 Zhejiang Hongyuan Pharmaceutical
6.16.1 Zhejiang Hongyuan Pharmaceutical Corporation Information
6.16.2 Zhejiang Hongyuan Pharmaceutical Atorvastatin Calcium Description and Business Overview
6.16.3 Zhejiang Hongyuan Pharmaceutical Atorvastatin Calcium Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Zhejiang Hongyuan Pharmaceutical Atorvastatin Calcium Product Portfolio
6.16.5 Zhejiang Hongyuan Pharmaceutical Recent Developments/Updates
6.17 Hubei Yitai Pharmaceutical
6.17.1 Hubei Yitai Pharmaceutical Corporation Information
6.17.2 Hubei Yitai Pharmaceutical Atorvastatin Calcium Description and Business Overview
6.17.3 Hubei Yitai Pharmaceutical Atorvastatin Calcium Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Hubei Yitai Pharmaceutical Atorvastatin Calcium Product Portfolio
6.17.5 Hubei Yitai Pharmaceutical Recent Developments/Updates
6.18 Jiangsu Hengrui Medicine
6.18.1 Jiangsu Hengrui Medicine Corporation Information
6.18.2 Jiangsu Hengrui Medicine Atorvastatin Calcium Description and Business Overview
6.18.3 Jiangsu Hengrui Medicine Atorvastatin Calcium Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Jiangsu Hengrui Medicine Atorvastatin Calcium Product Portfolio
6.18.5 Jiangsu Hengrui Medicine Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Atorvastatin Calcium Industry Chain Analysis
7.2 Atorvastatin Calcium Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Atorvastatin Calcium Production Mode & Process
7.4 Atorvastatin Calcium Sales and Marketing
7.4.1 Atorvastatin Calcium Sales Channels
7.4.2 Atorvastatin Calcium Distributors
7.5 Atorvastatin Calcium Customers
8 Atorvastatin Calcium Market Dynamics
8.1 Atorvastatin Calcium Industry Trends
8.2 Atorvastatin Calcium Market Drivers
8.3 Atorvastatin Calcium Market Challenges
8.4 Atorvastatin Calcium Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Atorvastatin Calcium Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Atorvastatin Calcium Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Atorvastatin Calcium Market Competitive Situation by Manufacturers in 2022
Table 4. Global Atorvastatin Calcium Sales (MT) of Key Manufacturers (2018-2023)
Table 5. Global Atorvastatin Calcium Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Atorvastatin Calcium Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Atorvastatin Calcium Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Atorvastatin Calcium Average Price (K USD/MT) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Atorvastatin Calcium, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Atorvastatin Calcium, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Atorvastatin Calcium, Product Type & Application
Table 12. Global Key Manufacturers of Atorvastatin Calcium, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Atorvastatin Calcium by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Atorvastatin Calcium as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Atorvastatin Calcium Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Atorvastatin Calcium Sales by Region (2018-2023) & (MT)
Table 18. Global Atorvastatin Calcium Sales Market Share by Region (2018-2023)
Table 19. Global Atorvastatin Calcium Sales by Region (2024-2029) & (MT)
Table 20. Global Atorvastatin Calcium Sales Market Share by Region (2024-2029)
Table 21. Global Atorvastatin Calcium Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Atorvastatin Calcium Revenue Market Share by Region (2018-2023)
Table 23. Global Atorvastatin Calcium Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Atorvastatin Calcium Revenue Market Share by Region (2024-2029)
Table 25. North America Atorvastatin Calcium Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Atorvastatin Calcium Sales by Country (2018-2023) & (MT)
Table 27. North America Atorvastatin Calcium Sales by Country (2024-2029) & (MT)
Table 28. North America Atorvastatin Calcium Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Atorvastatin Calcium Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Atorvastatin Calcium Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Atorvastatin Calcium Sales by Country (2018-2023) & (MT)
Table 32. Europe Atorvastatin Calcium Sales by Country (2024-2029) & (MT)
Table 33. Europe Atorvastatin Calcium Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Atorvastatin Calcium Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Atorvastatin Calcium Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Atorvastatin Calcium Sales by Region (2018-2023) & (MT)
Table 37. Asia Pacific Atorvastatin Calcium Sales by Region (2024-2029) & (MT)
Table 38. Asia Pacific Atorvastatin Calcium Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Atorvastatin Calcium Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Atorvastatin Calcium Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Atorvastatin Calcium Sales by Country (2018-2023) & (MT)
Table 42. Latin America Atorvastatin Calcium Sales by Country (2024-2029) & (MT)
Table 43. Latin America Atorvastatin Calcium Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Atorvastatin Calcium Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Atorvastatin Calcium Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Atorvastatin Calcium Sales by Country (2018-2023) & (MT)
Table 47. Middle East & Africa Atorvastatin Calcium Sales by Country (2024-2029) & (MT)
Table 48. Middle East & Africa Atorvastatin Calcium Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Atorvastatin Calcium Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Atorvastatin Calcium Sales (MT) by Type (2018-2023)
Table 51. Global Atorvastatin Calcium Sales (MT) by Type (2024-2029)
Table 52. Global Atorvastatin Calcium Sales Market Share by Type (2018-2023)
Table 53. Global Atorvastatin Calcium Sales Market Share by Type (2024-2029)
Table 54. Global Atorvastatin Calcium Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Atorvastatin Calcium Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Atorvastatin Calcium Revenue Market Share by Type (2018-2023)
Table 57. Global Atorvastatin Calcium Revenue Market Share by Type (2024-2029)
Table 58. Global Atorvastatin Calcium Price (K USD/MT) by Type (2018-2023)
Table 59. Global Atorvastatin Calcium Price (K USD/MT) by Type (2024-2029)
Table 60. Global Atorvastatin Calcium Sales (MT) by Application (2018-2023)
Table 61. Global Atorvastatin Calcium Sales (MT) by Application (2024-2029)
Table 62. Global Atorvastatin Calcium Sales Market Share by Application (2018-2023)
Table 63. Global Atorvastatin Calcium Sales Market Share by Application (2024-2029)
Table 64. Global Atorvastatin Calcium Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Atorvastatin Calcium Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Atorvastatin Calcium Revenue Market Share by Application (2018-2023)
Table 67. Global Atorvastatin Calcium Revenue Market Share by Application (2024-2029)
Table 68. Global Atorvastatin Calcium Price (K USD/MT) by Application (2018-2023)
Table 69. Global Atorvastatin Calcium Price (K USD/MT) by Application (2024-2029)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Atorvastatin Calcium Sales (MT), Revenue (US$ Million), Price (K USD/MT) and Gross Margin (2018-2023)
Table 73. Pfizer Atorvastatin Calcium Product
Table 74. Pfizer Recent Developments/Updates
Table 75. DSM Sinochem Pharmaceuticals Corporation Information
Table 76. DSM Sinochem Pharmaceuticals Description and Business Overview
Table 77. DSM Sinochem Pharmaceuticals Atorvastatin Calcium Sales (MT), Revenue (US$ Million), Price (K USD/MT) and Gross Margin (2018-2023)
Table 78. DSM Sinochem Pharmaceuticals Atorvastatin Calcium Product
Table 79. DSM Sinochem Pharmaceuticals Recent Developments/Updates
Table 80. Ind-Swift Corporation Information
Table 81. Ind-Swift Description and Business Overview
Table 82. Ind-Swift Atorvastatin Calcium Sales (MT), Revenue (US$ Million), Price (K USD/MT) and Gross Margin (2018-2023)
Table 83. Ind-Swift Atorvastatin Calcium Product
Table 84. Ind-Swift Recent Developments/Updates
Table 85. Cadila Pharmaceuticals Corporation Information
Table 86. Cadila Pharmaceuticals Description and Business Overview
Table 87. Cadila Pharmaceuticals Atorvastatin Calcium Sales (MT), Revenue (US$ Million), Price (K USD/MT) and Gross Margin (2018-2023)
Table 88. Cadila Pharmaceuticals Atorvastatin Calcium Product
Table 89. Cadila Pharmaceuticals Recent Developments/Updates
Table 90. Morepen Corporation Information
Table 91. Morepen Description and Business Overview
Table 92. Morepen Atorvastatin Calcium Sales (MT), Revenue (US$ Million), Price (K USD/MT) and Gross Margin (2018-2023)
Table 93. Morepen Atorvastatin Calcium Product
Table 94. Morepen Recent Developments/Updates
Table 95. Sun Pharmaceutical Industries Corporation Information
Table 96. Sun Pharmaceutical Industries Description and Business Overview
Table 97. Sun Pharmaceutical Industries Atorvastatin Calcium Sales (MT), Revenue (US$ Million), Price (K USD/MT) and Gross Margin (2018-2023)
Table 98. Sun Pharmaceutical Industries Atorvastatin Calcium Product
Table 99. Sun Pharmaceutical Industries Recent Developments/Updates
Table 100. MSN Laboratories Corporation Information
Table 101. MSN Laboratories Description and Business Overview
Table 102. MSN Laboratories Atorvastatin Calcium Sales (MT), Revenue (US$ Million), Price (K USD/MT) and Gross Margin (2018-2023)
Table 103. MSN Laboratories Atorvastatin Calcium Product
Table 104. MSN Laboratories Recent Developments/Updates
Table 105. Dr. Reddy's Corporation Information
Table 106. Dr. Reddy's Description and Business Overview
Table 107. Dr. Reddy's Atorvastatin Calcium Sales (MT), Revenue (US$ Million), Price (K USD/MT) and Gross Margin (2018-2023)
Table 108. Dr. Reddy's Atorvastatin Calcium Product
Table 109. Dr. Reddy's Recent Developments/Updates
Table 110. Teva Pharmaceutical Industries Corporation Information
Table 111. Teva Pharmaceutical Industries Description and Business Overview
Table 112. Teva Pharmaceutical Industries Atorvastatin Calcium Sales (MT), Revenue (US$ Million), Price (K USD/MT) and Gross Margin (2018-2023)
Table 113. Teva Pharmaceutical Industries Atorvastatin Calcium Product
Table 114. Teva Pharmaceutical Industries Recent Developments/Updates
Table 115. Apotex Pharmachem Corporation Information
Table 116. Apotex Pharmachem Description and Business Overview
Table 117. Apotex Pharmachem Atorvastatin Calcium Sales (MT), Revenue (US$ Million), Price (K USD/MT) and Gross Margin (2018-2023)
Table 118. Apotex Pharmachem Atorvastatin Calcium Product
Table 119. Apotex Pharmachem Recent Developments/Updates
Table 120. Zheijang Neo-Dankon Pharmaceutical Corporation Information
Table 121. Zheijang Neo-Dankon Pharmaceutical Description and Business Overview
Table 122. Zheijang Neo-Dankon Pharmaceutical Atorvastatin Calcium Sales (MT), Revenue (US$ Million), Price (K USD/MT) and Gross Margin (2018-2023)
Table 123. Zheijang Neo-Dankon Pharmaceutical Atorvastatin Calcium Product
Table 124. Zheijang Neo-Dankon Pharmaceutical Recent Developments/Updates
Table 125. Ningbo Menovo Pharmaceuticals Group Corporation Information
Table 126. Ningbo Menovo Pharmaceuticals Group Description and Business Overview
Table 127. Ningbo Menovo Pharmaceuticals Group Atorvastatin Calcium Sales (MT), Revenue (US$ Million), Price (K USD/MT) and Gross Margin (2018-2023)
Table 128. Ningbo Menovo Pharmaceuticals Group Atorvastatin Calcium Product
Table 129. Ningbo Menovo Pharmaceuticals Group Recent Developments/Updates
Table 130. Jialin Pharmaceutical Corporation Information
Table 131. Jialin Pharmaceutical Description and Business Overview
Table 132. Jialin Pharmaceutical Atorvastatin Calcium Sales (MT), Revenue (US$ Million), Price (K USD/MT) and Gross Margin (2018-2023)
Table 133. Jialin Pharmaceutical Atorvastatin Calcium Product
Table 134. Jialin Pharmaceutical Recent Developments/Updates
Table 135. Topfond Corporation Information
Table 136. Topfond Description and Business Overview
Table 137. Topfond Atorvastatin Calcium Sales (MT), Revenue (US$ Million), Price (K USD/MT) and Gross Margin (2018-2023)
Table 138. Topfond Atorvastatin Calcium Product
Table 139. Topfond Recent Developments/Updates
Table 140. Zhejiang Hisun Pharmacutical Corporation Information
Table 141. Zhejiang Hisun Pharmacutical Description and Business Overview
Table 142. Zhejiang Hisun Pharmacutical Atorvastatin Calcium Sales (MT), Revenue (US$ Million), Price (K USD/MT) and Gross Margin (2018-2023)
Table 143. Zhejiang Hisun Pharmacutical Atorvastatin Calcium Product
Table 144. Zhejiang Hisun Pharmacutical Recent Developments/Updates
Table 145. Zhejiang Hongyuan Pharmaceutical Corporation Information
Table 146. Zhejiang Hongyuan Pharmaceutical Description and Business Overview
Table 147. Zhejiang Hongyuan Pharmaceutical Atorvastatin Calcium Sales (MT), Revenue (US$ Million), Price (K USD/MT) and Gross Margin (2018-2023)
Table 148. Zhejiang Hongyuan Pharmaceutical Atorvastatin Calcium Product
Table 149. Zhejiang Hongyuan Pharmaceutical Recent Developments/Updates
Table 150. Hubei Yitai Pharmaceutical Corporation Information
Table 151. Hubei Yitai Pharmaceutical Description and Business Overview
Table 152. Hubei Yitai Pharmaceutical Atorvastatin Calcium Sales (MT), Revenue (US$ Million), Price (K USD/MT) and Gross Margin (2018-2023)
Table 153. Hubei Yitai Pharmaceutical Atorvastatin Calcium Product
Table 154. Hubei Yitai Pharmaceutical Recent Developments/Updates
Table 155. Jiangsu Hengrui Medicine Corporation Information
Table 156. Jiangsu Hengrui Medicine Description and Business Overview
Table 157. Jiangsu Hengrui Medicine Atorvastatin Calcium Sales (MT), Revenue (US$ Million), Price (K USD/MT) and Gross Margin (2018-2023)
Table 158. Jiangsu Hengrui Medicine Atorvastatin Calcium Product
Table 159. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Atorvastatin Calcium Distributors List
Table 163. Atorvastatin Calcium Customers List
Table 164. Atorvastatin Calcium Market Trends
Table 165. Atorvastatin Calcium Market Drivers
Table 166. Atorvastatin Calcium Market Challenges
Table 167. Atorvastatin Calcium Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Atorvastatin Calcium
Figure 2. Global Atorvastatin Calcium Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Atorvastatin Calcium Market Share by Type in 2022 & 2029
Figure 4. Chemical Synthesis Product Picture
Figure 5. Biocatalysis Product Picture
Figure 6. Global Atorvastatin Calcium Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Atorvastatin Calcium Market Share by Application in 2022 & 2029
Figure 8. Tablet (Including Dispersible Tablet and General Tablet)
Figure 9. Capsule
Figure 10. Others
Figure 11. Global Atorvastatin Calcium Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Atorvastatin Calcium Market Size (2018-2029) & (US$ Million)
Figure 13. Global Atorvastatin Calcium Sales (2018-2029) & (MT)
Figure 14. Global Atorvastatin Calcium Average Price (K USD/MT) & (2018-2029)
Figure 15. Atorvastatin Calcium Report Years Considered
Figure 16. Atorvastatin Calcium Sales Share by Manufacturers in 2022
Figure 17. Global Atorvastatin Calcium Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Atorvastatin Calcium Players: Market Share by Revenue in 2022
Figure 19. Atorvastatin Calcium Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Atorvastatin Calcium Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Atorvastatin Calcium Sales Market Share by Country (2018-2029)
Figure 22. North America Atorvastatin Calcium Revenue Market Share by Country (2018-2029)
Figure 23. U.S. Atorvastatin Calcium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Atorvastatin Calcium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Atorvastatin Calcium Sales Market Share by Country (2018-2029)
Figure 26. Europe Atorvastatin Calcium Revenue Market Share by Country (2018-2029)
Figure 27. Germany Atorvastatin Calcium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Atorvastatin Calcium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Atorvastatin Calcium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Atorvastatin Calcium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Atorvastatin Calcium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Atorvastatin Calcium Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Atorvastatin Calcium Revenue Market Share by Region (2018-2029)
Figure 34. China Atorvastatin Calcium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Atorvastatin Calcium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Atorvastatin Calcium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Atorvastatin Calcium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Atorvastatin Calcium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Atorvastatin Calcium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Atorvastatin Calcium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Atorvastatin Calcium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Atorvastatin Calcium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Philippines Atorvastatin Calcium Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Atorvastatin Calcium Sales Market Share by Country (2018-2029)
Figure 45. Latin America Atorvastatin Calcium Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Atorvastatin Calcium Revenue G
  • Global Digoxin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 75
    According to our LPI (LP Information) latest study, the global Digoxin market size was valued at US$ 59 million in 2023. With growing demand in downstream market, the Digoxin is forecast to a readjusted size of US$ 73 million by 2030 with a CAGR of 3.2% during review period. The research report highlights the growth potential of the global Digoxin market. Digoxin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain op......
  • Global Heart Failure Drugs Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116
    According to our LPI (LP Information) latest study, the global Heart Failure Drugs market size was valued at US$ million in 2023. With growing demand in downstream market, the Heart Failure Drugs is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Heart Failure Drugs market. Heart Failure Drugs are expected to show stable growth in the future market. However, product differentiatio......
  • Global Atorvastatin Calcium Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 138
    According to our LPI (LP Information) latest study, the global Atorvastatin Calcium market size was valued at US$ 214.2 million in 2023. With growing demand in downstream market, the Atorvastatin Calcium is forecast to a readjusted size of US$ 362 million by 2030 with a CAGR of 7.8% during review period. The research report highlights the growth potential of the global Atorvastatin Calcium market. Atorvastatin Calcium are expected to show stable growth in the future market. However, prod......
  • Global Rosuvastatin Calcium Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 139
    According to our LPI (LP Information) latest study, the global Rosuvastatin Calcium market size was valued at US$ 514.3 million in 2023. With growing demand in downstream market, the Rosuvastatin Calcium is forecast to a readjusted size of US$ 683.6 million by 2030 with a CAGR of 4.1% during review period. The research report highlights the growth potential of the global Rosuvastatin Calcium market. Rosuvastatin Calcium are expected to show stable growth in the future market. However, pr......
  • Global Atorvastatin Calcium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 133
    According to our (Global Info Research) latest study, the global Atorvastatin Calcium market size was valued at USD 225.3 million in 2023 and is forecast to a readjusted size of USD 366.1 million by 2030 with a CAGR of 7.2% during review period. Atorvastatin calcium is a pharmaceutical raw material in the production of atorvastatin calcium drug (trade name: Lipitor), which is a prescription medicine that lowers the LDL cholesterol and triglycerides in the blood and can raise HDL choleste......
  • Global Rosuvastatin Calcium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 132
    According to our (Global Info Research) latest study, the global Rosuvastatin Calcium market size was valued at USD 540.9 million in 2023 and is forecast to a readjusted size of USD 703.6 million by 2030 with a CAGR of 3.8% during review period. Rosuvastatin calcium (CAS 147098-20-2, molecular formula being C44H54CaF2N6O12S2) is the active pharmaceutical ingredient for the once-a-day dyslipidaemia treatment Crestor, it is one approved API which can be used to reduce the risk of heart att......
  • Cilostazol - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 118
    The global Cilostazol market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Cilostazol in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Cilostazol market. Injection Cilostazol, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Freeze-dried P......
  • Rosuvastatin - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 110
    Rosuvastatin medication is a statin that is used to lower bad cholesterol and prevent cardiovascular disease. It works by blocking an enzyme in the liver that makes cholesterol. It is taken by mouth and should be used together with dietary changes, exercise, and weight loss. It may also raise good cholesterol and lower triglycerides. It is sold under the brand name Crestor among others. It may be used when other statins have not worked well. The global Rosuvastatin market size is expected......
  • Global Congestive Heart Failure Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 19-Dec-2023        Price: US 3380 Onwards        Pages: 123
    Market Overview of Global Congestive Heart Failure Drugs market: According to our latest research, the global Congestive Heart Failure Drugs market looks promising in the next 5 years. As of 2022, the global Congestive Heart Failure Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Congestive heart failure is a serious and complex condition in which the heart muscles are either dam......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs